(Q26778392)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Systematic review and meta-analysis of the efficacy and safety of perampanel in the treatment of partial-onset epilepsy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Profile of perampanel and its potential in the treatment of partial onset seizures

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Antiepileptic drug trials: the view from the clinic

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Antiepileptic drug monotherapy versus polytherapy: pursuing seizure freedom and tolerability in adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

28 September 2017

Drug-resistant epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

28 September 2017

Epilepsy in later life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Interpreting regulatory trials in epilepsy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Second-generation antiepileptic drugs' impact on balance: a meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Levetiracetam in refractory epilepsy: a prospective observational study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Epilepsy: comorbidity in the elderly

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Adverse drug reactions: definitions, diagnosis, and management

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Discontinuation of levetiracetam because of behavioral side effects: a case-control study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

Meta-analyses of antiepileptic drugs for refractory partial (focal) epilepsy: an observation

31 May 2018

1 reference

Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?

21 January 2018

1 reference

Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.

21 January 2018

1 reference

Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.

21 January 2018

1 reference

Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305

21 January 2018

1 reference

First clinical experiences with perampanel--the Kork experience in 74 patients.

21 January 2018

1 reference

A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria

21 January 2018

1 reference

New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine

21 January 2018

1 reference

An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.

21 January 2018

1 reference

The tolerability of lamotrigine in elderly patients with epilepsy

21 January 2018

1 reference

Safety and tolerability of oxcarbazepine in elderly patients with epilepsy

21 January 2018

1 reference

The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study.

21 January 2018

1 reference

Safety and tolerability of zonisamide in elderly patients with epilepsy

21 January 2018

1 reference

Adverse effects of antiepileptic drugs

21 January 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4738453

21 January 2018

Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases

28 November 2018

1 reference

Psychiatric adverse events during levetiracetam therapy

21 January 2018

1 reference

Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam

21 January 2018

1 reference

Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial

21 January 2018

1 reference

Levetiracetam monotherapy--outcomes from an epilepsy clinic.

21 January 2018

1 reference

A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.

21 January 2018

1 reference

Topiramate and psychiatric adverse events in patients with epilepsy

21 January 2018

1 reference

Tolerability and safety of perampanel: two randomized dose-escalation studies.

21 January 2018

1 reference

Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26506904

12 December 2020

inferred from PubMed ID database lookup

A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26506904

12 December 2020

inferred from PubMed ID database lookup

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26506904

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1111/ANE.12529

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1161579

Fatcat ID

release_pg4l3rxavrgvtfkinaan7h6d5q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pg4l3rxavrgvtfkinaan7h6d5q

24 November 2022

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1161579

1 reference